Focusing sharply on its core business resulted in a 68 per cent compound annual growth rate (CAGR), reducing adjusted negative EBITDA from Rs 162 crore to Rs 17 crore
Read MoreThe company's mission focuses on reducing avoidable blindness in India by developing affordable and portable ophthalmic screening devices
Read MoreThe healthcare IT market was worth USD 303.4 billion in 2022 and is anticipated to exhibit a 13.5 per cent CAGR from 2023–2032 owing to rising investments in healthcare infrastructure in Asian countries
Read MoreAccording to a report by Grand View Research, the global medical device market size was valued at USD 425.5 billion in 2020 and is expected to grow at a CAGR of 5.4 per cent from 2021 to 2028
Read More